Reset filters
  • 12 September 2017

New US PrEP cost-effectiveness model finds drug prices will need to drop substantially if HIV risk rises, or if adherence is only moderate

Read the article
  • 11 September 2017

Maraviroc matches boosted protease inhibitor treatment over 96 weeks

Read the article
  • 8 September 2017

What's going on in gay men’s lives when they acquire HIV?

Read the article
Image of the adapted socio-ecological framework used in the study.
  • 8 September 2017

What is going on in gay men’s lives when they acquire HIV?

Read the article
Image of the adapted socio-ecological framework used in the study.
  • 7 September 2017

No new HIV infections among Kaiser PrEP users, but data shows missed opportunities

Read the article
  • 6 September 2017

Lipids improved by switching from ritonavir to cobicistat as a booster for darunavir

Read the article
  • 5 September 2017

Case reports of severe dolutegravir-related depression

Read the article
  • 1 September 2017

Experts concur that event-related oral PrEP probably won’t work for women

Read the article
  • 31 August 2017

Taking dolutegravir in the morning may avert insomnia

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.